Waystar Holding, a healthcare technology company, received a buy rating due to its impressive 18% revenue growth, 34% subscription growth, and a 42.8% adjusted EBITDA margin. The company's expanding AI capabilities and recent acquisition of Iodine Software enhance its platform value and increase its addressable market by over 15%. With subscription revenue and a net revenue retention rate of 108%, Waystar demonstrates a stable recurring revenue base supported by strong client expansion and upselling. Its valuation remains attractive with a forward P/E of 15.01x and EV/EBITDA of 11.25x, alongside upwardly revised guidance for 2026, indicating potential for further growth.
Hayati®, a UK-based technology and vaping brand, partnered with elrow at the Edinburgh Festival to launch the "TURN UP WITH HAYATI®" activation. This collaboration featured a dedicated space with interactive activities, special festival edition produ...
FREELANDER participated in the 2026 Chery International User Summit in Wuhu, China, showcasing the international variant of its FREELANDER 8 model through a day-and-night program on October 19. The day featured the first international test drive on c...
Bitcoin (BTC) climbed 0.89% to surpass $82,000, with Ether (ETH) also gaining 0.45% near $2,400. The crypto market showed mixed performance: Monero (XMR) and Zcash (ZEC) rose over 2%, while sectors like Layer 1 and CeFi advanced modestly. However, so...
The Bitwise NEAR ETF (NRR) held 16.5 million NEAR tokens valued at over $82 million as of mid-October, with all assets staked to earn rewards. The fund reported a 3.31% net staking reward rate on Oct. 16, lower than the 4.94% gross rate, due to fees ...
South32 Ltd began fiscal year 2027 with an 11% rise in copper production at its Sierra Gorda mine, driven by higher ore grades and ongoing expansion efforts including a new grinding line to increase capacity by 25%. The company also saw a 14% increas...
